RNF26 anticorps (N-Term)

N° du produit ABIN6992190

Détail du produit anti-RNF26 anticorps

Antigène: RNF26 (Ring Finger Protein 26 (RNF26))

Épitope: N-Term

Reactivité: Humain, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp RNF26 est non-conjugé

Application: ELISA, Western Blotting (WB)

Specificité: RNF26 Antibody is predicted to not cross-react with other CXCR familiy members.

Purification: RNF26 Antibody is affinity chromatography purified via peptide column.

Immunogène: RNF26 antibody was raised against a peptide corresponding to 14 amino acids near the amino terminus of human RNF26.

Isotype: IgG

Information d'application

Indications d'application: RNF26 antibody can be used for Western blot at 1 - 2 μ,g/mL.

Antibody validated: Western Blot in human and rat samples. All other applications and species not yet tested.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: RNF26 Antibody is supplied in PBS containing 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,4 °C

Stockage commentaire: RNF26 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Détails sur RNF26

Antigène: RNF26 (Ring Finger Protein 26 (RNF26))

Autre désignation: RNF26 (RNF26 Produits)

Synonymes: anticorps 8030450I18Rik, anticorps ring finger protein 26, anticorps RNF26, anticorps Rnf26

Sujet: RNF26 Antibody: RNF26 was identified as a member of a novel C3HC5 ring finger subfamily (1). RNF26 is ubiquitously expressed in human tissues but has been found to be upregulated in several cancer cell lines including HL-60, HeLa S3, and SW480, as well as 50 % of primary gastric cancers. While the substrates of RNF26 ubiquitination have not yet been identified, the upregulation of RNF26 in several types of cancer suggest that it may serve as a target for therapeutic treatment (1).

Poids moléculaire: Predicted: 48 kDa

Observed: 50 kDa

ID gène: 79102

NCBI Accession: NP_114404

UniProt: Q9BY78